The 20 Best Apoplexy Doctors near Towson, MD

Dr. Seamus Whelton MD, MPH, is an Associate Professor of Cardiology and member of the Ciccarone Center for the Prevention of Cardiovascular Disease. His primary clinical and research expertise includes the pathogenesis, risk prediction, prevention, and treatment of atherosclerotic cardiovascular disease with an emphasis on the identification of coronary artery calcium via cardiac CT scanning. He is Director of the Advanced Subclinical Atherosclerosis Clinic, which focuses on the treatment of patients with incidentally discovered coronary artery calcium detected by CT imaging. He is also an expert on the pathogenesis, epidemiology, and risk factors for aortic valve calcification. He has led pioneering research to describe the use aortic valve calcification to predict the risk of aortic stenosis. Dr. Whelton has published more than 130 peer reviewed manuscripts, multiple book chapters, and has been an invited lecturer at both national and international conferences. He is an Associate Editor at the Journal of Cardiovascular Computed Tomography and the American Journal of Preventive Cardiology. He is a member of the American College of Cardiology Prevention of Cardiovascular Disease Leadership Council. He has been the Principal Investigator on grants from the National Institutes of Health and American Heart Association. Dr. Whelton received his undergraduate degree at Princeton University. He then completed a Masters of Public Health in Epidemiology at the Tulane University School of Public Health and Tropical Medicine followed by his Doctor of Medicine degree from the Tulane University School of Medicine. He subsequently completed a post-doctoral fellowship at the Welch Center for Prevention, Epidemiology and Clinical Research at the Johns Hopkins Bloomberg School of Public Health and then completed a fellowship in Cardiology at the Johns Hopkins School of Medicine before joining the Cardiology Faculty at Johns Hopkins in 2017. Videos Dr. Seamus Whelton. Dr. Whelton is rated as a Distinguished provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Atherosclerosis, Apoplexy, Coronary Heart Disease, Pacemaker Implantation, and Heart Bypass Surgery.

Mark Kelemen is a Cardiologist in Baltimore, Maryland. Dr. Kelemen is rated as a Distinguished provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Apoplexy, Pulmonary Edema, Heart Failure, Heart Attack, and Pacemaker Implantation.

Henry Sun is an Interventional Cardiologist in Baltimore,, Maryland. Dr. Sun is rated as a Distinguished provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Coronary Heart Disease, Heart Attack, Apoplexy, Heart Bypass Surgery, and Pacemaker Implantation.

Vikas Kalra is a Cardiac Electrophysiologist and a Cardiologist in Towson, Maryland. Dr. Kalra is rated as an Experienced provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Atrial Fibrillation, Familial Ventricular Tachycardia, Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation. Dr. Kalra is currently accepting new patients.

Dr. Andreas S. Barth is an Associate Professor in the Division of Cardiology at the Johns Hopkins School of Medicine and Director of the Center for Inherited Heart Diseases. His clinical work focuses on clinical cardiac electrophysiology with a specific focus on inherited arrhythmia syndromes and channelopathies, including long QT syndrome, Brugada syndrome, CPVT and arrhythmogenic cardiomyopathies. Additionally, Dr. Barth participates in a multidisciplinary clinic at Kennedy Krieger Institute providing Cardiology care to patients with muscular dystrophies and mitochondrial disease. Dr. Barth performs pacemaker and defibrillator implantation and complex catheter ablations for atrial and ventricular arrhythmias. His basic research lab explores the relationship between metabolic and arrhythmogenic ion channel remodeling in heart failure and myotonic dystrophy. Dr. Barth earned a combined doctor of medicine and doctor of philosophy from the Ludwig-Maximilians-University in Munich, Germany. He joined the Johns Hopkins faculty in 2016. He has been recognized with the First Prize for the Stanley L. Blumenthal Cardiology Research Award in Clinical Science in the Division of Cardiology at Johns Hopkins Hospital, and as a Young Investigator Award Finalist of the American Heart Association and Heart Rhythm Society. Dr. Barth is rated as an Advanced provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Cardiomyopathy, Arrhythmias, Heart Attack, Cardiac Ablation, and Pacemaker Implantation.

Dr. Stacy Fisher is a cardiologist in Baltimore, Maryland specializing in the care of adult congenital heart disease, pregnancy-related heart disease and congenital heart pulmonary hypertension. She is Associate Director of the Adult Congenital Heart Disease (ACHD) Center at the Johns Hopkins Heart and Vascular Institute and Director of the ACHD Training Program. She is also an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her research focus is congenital heart disease in adults including pulmonary hypertension, inherited heart disease and 3D printing translational medicine. She is interested in imaging and using 3D modeling to advance cardiac care and education. Her education includes a Bachelor of Science degree in Microbiology from Miami University in Oxford, Ohio, and a Doctor of Medicine Degree from the University of Maryland School of Medicine in Baltimore, Maryland. She completed an internship and residency in Internal Medicine at Duke University in Durham, North Carolina. Her fellowship in cardiology was at the University of Rochester, Strong Memorial Hospital in Rochester, New York, including serving as the Chief Cardiology Fellow. She was then an Adult Congenital Heart Fellow at the University of Rochester, Strong Memorial Hospital. After completing her fellowship in 2001, she joined a Baltimore cardiology practice and was named Director of Women’s Cardiovascular Services and the Co-Director of the Cardiac Critical Care Unit at Sinai Hospital in Baltimore, positions which she held until 2011. She then joined University of Maryland School of Medicine as Director of Women’s and Complex Heart diseases where she started and directed the Adult Congenital Heart Program and practiced through 2022 when she joined Johns Hopkins. She was recently the President of the American Heart Association’s Greater Maryland Region. Videos Dr. Stacy Fisher. Dr. Fisher is rated as an Advanced provider by MediFind in the treatment of Apoplexy. Her top areas of expertise are Familial Ventricular Tachycardia, Arrhythmias, Ventricular Tachycardia, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Reed David Riley is an assistant professor of medicine at the Johns Hopkins University School of Medicine and chief of cardiology at the Greater Baltimore Medical Center. Dr. Riley received his undergraduate degree from Duke University. He earned a medical degree from The Johns Hopkins University School of Medicine and completed a residency at Johns Hopkins Hospital. Prior to joining Johns Hopkins in 2007, Dr. Riley was a cardiology fellow at Duke University and staff cardiologist at Sinai Hospital of Baltimore. He is currently also a teaching attending on the Osler Medical Service’s Barker Firm at the Johns Hopkins Hospital. Dr. Riley is rated as an Advanced provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Heart Attack, Atrial Fibrillation, Apoplexy, and Angina.

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Advanced provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Advanced provider by MediFind in the treatment of Apoplexy. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Heart Failure, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Jonathan Chrispin, M.D., is an Associate Professor of Medicine in the Johns Hopkins Medicine Division of Cardiology, Electrophysiology and Arrhythmia, as well as an Associate Professor of Biomedical Engineering at Johns Hopkins University. Dr. Chrispin focuses on all aspects of clinical electrophysiology, including pacemaker/defibrillator implantation and complex catheter ablation for atrial and ventricular arrhythmias. Dr. Chrispin received his Bachelor of Arts degree from Harvard University. He received his Doctor of Medicine degree from Vanderbilt University. He completed intern and residency training in internal medicine at The Johns Hopkins Hospital, where he also completed a fellowship in cardiovascular disease and served as chief clinical cardiac electrophysiology fellow. He is a member of the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society. Dr. Chrispin directs the Ventricular Arrhythmia Ablation and Research program, focusing on using advanced cardiac imaging to better understand the structural substrate associated with the development of ventricular arrhythmias and using artificial intelligence to improve the risk stratification of sudden cardiac death. Further, he is involved in developing clinical trials to improve the safety and efficacy of catheter ablation for the treatment of ventricular tachycardia. His work has led to Dr. Chrispin publishing in a number of international journals, including Circulation, the Journal of the American College of Cardiology, Heart Rhythm Journal, Nature Cardiovascular Research, Journal of the American Heart Association, and EP Europace. Dr. Chrispin is rated as an Advanced provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Sarcoidosis, Cardiac Ablation, and Pacemaker Implantation.

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Advanced provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Jennifer Tanio is a cardiologist at the Johns Hopkins Health Care and Surgery Center at Green Spring Station. Dr. Tanio received her B.A. from Johns Hopkins University and her M.D. from the University of Pennsylvania School of Medicine. She completed her residency at the University of Pennsylvania and pursued cardiology fellowships at the University of Pennsylvania and the Johns Hopkins University School of Medicine. Dr. Tanio worked in private practice before joining the Johns Hopkins cardiology faculty. Dr. Tanio’s clinical expertise includes preventive cardiology and heart disease. Dr. Tanio is rated as an Advanced provider by MediFind in the treatment of Apoplexy. Her top areas of expertise are Mitral Valve Prolapse, Heart Attack, Atherosclerosis, and Coronary Heart Disease.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Advanced provider by MediFind in the treatment of Apoplexy. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Tala K Al-Talib, M.D. is a cardiologist in Baltimore, MD. She is the Medical Director of Johns Hopkins Medicine – Cardiology at Johns Hopkins Greenspring Station. Dr. Al-Talib’s clinical areas of focus are in general and preventative cardiology. She specializes in cardiovascular disease in women, with a particular interest in cardiovascular risk assessment and treatment of cardiac conditions in women with breast cancer or other oncological history. She was integral in the establishment of the Preventative Cardiology Program to Improve Heart Health for Female Breast Cancer Survivors, a collaborative effort to detect asymptomatic cardiovascular disease and ultimately prevent cardiovascular events in this patient group. After receiving her medical degree from University of Maryland School of Medicine, Dr. Al-Talib completed her residency in Internal Medicine at the University of Maryland Medical Center, where she was Chief Medical Resident. She completed her post-doctoral fellowship in cardiovascular medicine at University of Maryland Medical Center. In addition to her clinical practice, Dr. Al-Talib also serves as an inpatient echocardiographer at Bayview Medical Center, performing transesophageal echo (TEE) and cardioversions and attends on the inpatient cardiology services. Videos Red Chair SeriesDr. Tala Al-Talib. Dr. Al is rated as an Advanced provider by MediFind in the treatment of Apoplexy. Her top areas of expertise are Heart Attack, Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, and Apoplexy.

Stacey Schott, M.D., M.P.H., is a preventive cardiologist and an assistant professor in the cardiovascular division at the Johns Hopkins University School of Medicine. She specializes in preventive cardiology, cardiovascular disease, heart disease, echocardiography and nuclear cardiology. Dr. Schott is a member of the Academy of Communication in Healthcare, an organization committed to improving relationship-centered health care communication. She is also a member of The American Society for Preventive Cardiology and the American College of Preventive Medicine. Dr. Schott’s research focuses on preventive cardiology, cardiovascular disease and health care communication. Dr. Schott is rated as an Advanced provider by MediFind in the treatment of Apoplexy. Her top areas of expertise are Heart Failure, Heart Attack, Apoplexy, and Inappropriate Sinus Tachycardia (IST).

Dr. Thomas Stephen Metkus is an assistant professor of cardiology at the Johns Hopkins University School of Medicine. His research focuses on using cardiac physiology for risk stratification and therapeutics in non-cardiac critical illness such as sepsis and the acute respiratory distress syndrome (ARDS), and optimizing the management of non-cardiac organ failure in primary cardiac diseases such as heart failure and acute coronary syndromes. Dr. Metkus received his undergraduate degree from Boston University College of Engineering. He earned a medical degree from the University of Pennsylvania School of Medicine and completed a residency at Brigham and Women’s Hospital. After completing residency, Dr. Metkus was a clinical fellow at both Harvard Medical School and Johns Hopkins Hospital. Prior to joining the faculty at the Johns Hopkins Medical School he was an instructor of medicine at the Harvard Medical School. His educational focus includes teaching clinical cardiology and critical care, echocardiography, and electrocardiography to students, residents, and fellows at the Johns Hopkins Hospital. Videos Dr. Thomas Metkus. Dr. Metkus is rated as a Distinguished provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, and Inappropriate Sinus Tachycardia (IST).

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as a Distinguished provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as a Distinguished provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Thorsten Leucker is a Cardiologist in Baltimore, Maryland. Dr. Leucker is rated as a Distinguished provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Apoplexy, Heart Attack, Heterozygous Familial Hypercholesterolemia (HeFH), and Homozygous Familial Hypercholesterolemia (HoFH).

Dr. Brian Gustav Kral is Assistant Professor in the Division of Cardiology and General Internal Medicine as well as Assistant Professor of Radiology and Radiological Sciences at the Johns Hopkins School of Medicine. He is currently engaged in research on genetic and biological mechanisms of coronary atherosclerosis with an emphasis on plaque morphology and composition as well as coronary blood flow at different stages of disease progression. Dr. Kral received his undergraduate degree in economics and pre-medicine from The Johns Hopkins University. He received a master’s in public health from The Johns Hopkins School of Public Health. He also earned a medical degree from The Johns Hopkins School of Medicine. Dr. Kral completed his residency at the Mayo Graduate School of Medicine. He rejoined the Johns Hopkins community as a fellow in 2005 where he remained on Faculty after completion of his training. Besides his teaching and clinical engagements, Dr. Kral is currently the Program Director of Nuclear Cardiology at the Johns Hopkins School of Medicine. Dr. Kral is also Director of Clinical Studies for The Johns Hopkins GeneSTAR Research Program. The program aims to identify genetic and biological determinants of subclinical and clinical atherosclerotic disease and thrombosis in individuals with a strong family history of early-onset coronary artery disease. He has been recognized with the Stanley L. Blumenthal Cardiology Research Award for outstanding clinical research in cardiovascular disease from The Johns Hopkins Medical Institutions. Dr. Kral is rated as a Distinguished provider by MediFind in the treatment of Apoplexy. His top areas of expertise are Apoplexy, Coronary Heart Disease, Heart Attack, Pacemaker Implantation, and Aortic Valve Replacement.